vs
Side-by-side financial comparison of Ouster, Inc. (OUST) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $62.2M, roughly 1.2× Ouster, Inc.). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs 25.5%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $-37.2M). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs 22.7%).
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
OUST vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.2M | $76.2M |
| Net Profit | — | $5.6M |
| Gross Margin | 60.2% | 57.9% |
| Operating Margin | 1.5% | 11.0% |
| Net Margin | — | 7.4% |
| Revenue YoY | 106.6% | 25.5% |
| Net Profit YoY | — | 30.7% |
| EPS (diluted) | $0.10 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.2M | $76.2M | ||
| Q3 25 | $39.5M | $71.9M | ||
| Q2 25 | $35.0M | $63.1M | ||
| Q1 25 | $32.6M | $59.1M | ||
| Q4 24 | $30.1M | $60.7M | ||
| Q3 24 | $28.1M | $58.0M | ||
| Q2 24 | $27.0M | $55.0M | ||
| Q1 24 | $25.9M | $50.6M |
| Q4 25 | — | $5.6M | ||
| Q3 25 | $-21.7M | $3.5M | ||
| Q2 25 | $-20.6M | $3.2M | ||
| Q1 25 | $-22.0M | $2.6M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | $-25.6M | $3.9M | ||
| Q2 24 | $-23.9M | $1.5M | ||
| Q1 24 | $-23.8M | $1.6M |
| Q4 25 | 60.2% | 57.9% | ||
| Q3 25 | 42.1% | 57.5% | ||
| Q2 25 | 45.2% | 58.3% | ||
| Q1 25 | 41.3% | 56.3% | ||
| Q4 24 | 43.8% | 59.5% | ||
| Q3 24 | 38.3% | 59.3% | ||
| Q2 24 | 33.7% | 59.8% | ||
| Q1 24 | 28.6% | 58.9% |
| Q4 25 | 1.5% | 11.0% | ||
| Q3 25 | -61.4% | 7.8% | ||
| Q2 25 | -76.5% | 8.1% | ||
| Q1 25 | -73.0% | 6.5% | ||
| Q4 24 | -85.1% | 10.6% | ||
| Q3 24 | -98.0% | 9.7% | ||
| Q2 24 | -93.6% | 6.6% | ||
| Q1 24 | -99.5% | 4.4% |
| Q4 25 | — | 7.4% | ||
| Q3 25 | -55.0% | 4.9% | ||
| Q2 25 | -58.8% | 5.0% | ||
| Q1 25 | -67.5% | 4.4% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | -91.1% | 6.7% | ||
| Q2 24 | -88.4% | 2.7% | ||
| Q1 24 | -91.9% | 3.2% |
| Q4 25 | $0.10 | $0.14 | ||
| Q3 25 | $-0.37 | $0.09 | ||
| Q2 25 | $-0.38 | $0.08 | ||
| Q1 25 | $-0.42 | $0.06 | ||
| Q4 24 | $-0.46 | $0.10 | ||
| Q3 24 | $-0.54 | $0.10 | ||
| Q2 24 | $-0.53 | $0.04 | ||
| Q1 24 | $-0.55 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $208.6M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $261.7M | $141.5M |
| Total Assets | $349.5M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $208.6M | $13.5M | ||
| Q3 25 | $244.5M | $11.1M | ||
| Q2 25 | $226.5M | $20.0M | ||
| Q1 25 | $168.2M | $10.2M | ||
| Q4 24 | $172.0M | $17.5M | ||
| Q3 24 | $151.4M | $11.3M | ||
| Q2 24 | $184.2M | $8.8M | ||
| Q1 24 | $187.8M | $7.3M |
| Q4 25 | $261.7M | $141.5M | ||
| Q3 25 | $247.4M | $133.6M | ||
| Q2 25 | $221.0M | $139.7M | ||
| Q1 25 | $167.9M | $134.8M | ||
| Q4 24 | $180.9M | $131.4M | ||
| Q3 24 | $171.7M | $125.0M | ||
| Q2 24 | $170.6M | $119.4M | ||
| Q1 24 | $167.2M | $116.3M |
| Q4 25 | $349.5M | $199.2M | ||
| Q3 25 | $353.8M | $202.4M | ||
| Q2 25 | $321.8M | $184.6M | ||
| Q1 25 | $268.6M | $178.1M | ||
| Q4 24 | $276.1M | $177.1M | ||
| Q3 24 | $255.2M | $169.5M | ||
| Q2 24 | $309.9M | $163.9M | ||
| Q1 24 | $317.7M | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.4M | $18.4M |
| Free Cash FlowOCF − Capex | $-37.2M | $9.7M |
| FCF MarginFCF / Revenue | -59.8% | 12.7% |
| Capex IntensityCapex / Revenue | 35.0% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $-64.8M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.4M | $18.4M | ||
| Q3 25 | $-18.3M | $18.4M | ||
| Q2 25 | $-1.3M | $12.3M | ||
| Q1 25 | $-4.9M | $2.9M | ||
| Q4 24 | $-2.6M | $15.0M | ||
| Q3 24 | $-3.8M | $12.7M | ||
| Q2 24 | $-21.6M | $10.2M | ||
| Q1 24 | $-5.7M | $1.2M |
| Q4 25 | $-37.2M | $9.7M | ||
| Q3 25 | $-20.0M | $10.7M | ||
| Q2 25 | $-2.2M | $4.1M | ||
| Q1 25 | $-5.4M | $-12.6M | ||
| Q4 24 | $-4.0M | $3.2M | ||
| Q3 24 | $-4.3M | $1.7M | ||
| Q2 24 | $-22.0M | $1.2M | ||
| Q1 24 | $-7.1M | $-4.8M |
| Q4 25 | -59.8% | 12.7% | ||
| Q3 25 | -50.7% | 14.9% | ||
| Q2 25 | -6.3% | 6.5% | ||
| Q1 25 | -16.6% | -21.4% | ||
| Q4 24 | -13.3% | 5.2% | ||
| Q3 24 | -15.4% | 3.0% | ||
| Q2 24 | -81.5% | 2.3% | ||
| Q1 24 | -27.4% | -9.5% |
| Q4 25 | 35.0% | 11.5% | ||
| Q3 25 | 4.3% | 10.6% | ||
| Q2 25 | 2.5% | 12.9% | ||
| Q1 25 | 1.7% | 26.2% | ||
| Q4 24 | 4.8% | 19.5% | ||
| Q3 24 | 2.0% | 19.0% | ||
| Q2 24 | 1.3% | 16.3% | ||
| Q1 24 | 5.3% | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
